XBH-62

N/A

Report date: 2024/04/24 14:11:52

Base Information

Drug NameXBH-62
Drug Alias NameXBH-62XBH62
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-NECTIN4
TargetsNectin-4
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChance Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesChance Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A